Lung Cancer Clinical Trials in Miami, FL

View the best 10 lung cancer medical studies in Miami, Florida. Access promising new therapies by applying to a Miami-based Lung Cancer clinical trial.

Trials in Miami, Florida

Here are the top 10 medical studies for lung cancer in Miami, Florida

Phase 3 comparator arm +3 More

Chemotherapy

Recruiting1 awardPhase 2 & 3

This trial tests two drugs, MRTX849 and pembrolizumab, in patients with advanced lung cancer who have a specific genetic mutation. MRTX849 targets the mutation to stop cancer growth, while pembrolizumab boosts the immune system to fight the cancer. The study aims to see how well these treatments work alone and together.

HLX10

Monoclonal Antibodies

Recruiting3 awardsPhase 3

This trial is testing two different treatment combinations for patients with extensive-stage small cell lung cancer who have not received any prior treatment. One group will receive a new drug called Serplulimab along with standard chemotherapy, while the other group will receive an existing drug called Atezolizumab with the same chemotherapy. Both immunotherapy drugs aim to help the immune system fight cancer, and the chemotherapy drugs work by killing cancer cells. Atezolizumab has been shown to improve survival in small-cell lung cancer when combined with chemotherapy, changing the standard first-line therapy.

Whole-Brain Radiotherapy +1 More

Radiation Therapy

Recruiting2 awardsPhase 3

This trial compares the effect of stereotactic radiosurgery to standard of care memantine and whole brain radiation therapy that avoids the hippocampus for the treatment of small cell lung cancer that has spread to the brain.

[212Pb]VMT-α-NET

Radioisotope Therapy

Recruiting1 awardPhase 1 & 2

This trial is testing a new therapy to treat advanced neuroendocrine tumors using targeted alpha-particles.

ELI-002 7P

Recruiting1 awardPhase 1 & 2

This trial is testing a new treatment called ELI-002 7P for patients with specific types of cancer. The treatment helps the immune system recognize and attack these cancer cells. ELI-002 7P targets mutations that are common in various cancers and have been studied for their role in tumor growth and resistance to treatments.

Dyspnea Intervention

Behavioral Intervention

Recruiting1 award4 criteria

This trial aims to test a new intervention called BREEZE+ to help patients with advanced lung cancer manage their breathlessness. The intervention includes brief nurse-delivered sessions and a digital health app to teach

Nivolumab +1 More

Checkpoint Inhibitor

Recruiting1 awardPhase 2

This trial is testing whether cabozantinib alone or with nivolumab is better than other treatments for patients with a type of lung cancer called non-squamous non-small cell lung cancer. Cabozantinib stops cancer cells from growing, while nivolumab helps the immune system fight the cancer. The goal is to see if these treatments can help patients live longer without their cancer getting worse.

MRTX849 (Adagrasib)

Small Molecule Drug

Recruiting2 awardsPhase 3

This trial is testing a new drug called adagrasib against an existing chemotherapy drug, docetaxel. It focuses on patients with advanced lung cancer who have a specific genetic mutation (KRAS G12C) and have already had treatment. The new drug aims to block this mutation in cancer cells to stop their growth.

Local ablative therapy

Procedure

Recruiting1 awardPhase 2

This trial will test whether a treatment that ablates (destroys) cancer cells when MRD levels are rising can control metastatic NSCLC better than systemic therapy.

Treatment

Recruiting1 award4 criteria

This trial is testing a blood test to see if it can detect lung cancer early in high-risk individuals. Blood samples will be collected from participants who are getting a routine CT scan for lung cancer screening.

Popular Filters

Phase 3 Trials

Toripalimab + Tifcemalimab for Small Cell Lung Cancer

Recruiting1 awardPhase 3

Miami, Florida

This trial is testing the safety and effectiveness of using two drugs, toripalimab and tifcemalimab, either alone or together, as a follow-up treatment for patients with limited

Anti-tumor antibiotic

DZD9008 vs Chemotherapy for Lung Cancer

Recruiting2 awardsPhase 3

Plantation, Florida

"This trial is comparing a new drug called DZD9008 to standard chemotherapy in patients with a type of lung cancer called NSCLC that has a specific genetic mutation. The study aims to see

Topoisomerase I inhibitors

Lurbinectedin +/- Irinotecan for Small Cell Lung Cancer

Recruiting2 awardsPhase 3

West Palm Beach, Florida

This trial is testing two different experimental treatments for small cell lung cancer that has returned after one other treatment. One experimental treatment is a single drug, and the other experimental treatment is a combination of two drugs. The trial will compare how well the experimental treatments work to a standard treatment.

Alkylating agents

Pembrolizumab SC vs IV for Lung Cancer

Recruiting2 awardsPhase 3

Hollywood, Florida

This trial is testing a new way to give the cancer drug pembrolizumab as an injection under the skin for people with advanced lung cancer. The goal is to see if this method works as well as the traditional IV method. The study will also check if it is safe and effective when used with standard chemotherapy.

Chemotherapy

Adagrasib + Pembrolizumab for Lung Cancer

Recruiting1 awardPhase 2 & 3

Miami, Florida

This trial tests two drugs, MRTX849 and pembrolizumab, in patients with advanced lung cancer who have a specific genetic mutation. MRTX849 targets the mutation to stop cancer growth, while pembrolizumab boosts the immune system to fight the cancer. The study aims to see how well these treatments work alone and together.

Alkylating agents

Pembrolizumab + Chemotherapy for Lung Cancer

Recruiting2 awardsPhase 3

Mobile, Alabama

This trial is studying whether giving first-line pembrolizumab followed by pemetrexed and carboplatin with or without pembrolizumab works better in treating patients with advanced non-squamous non-small cell lung cancer.

Trials With No Placebo

ELI-002 for Colorectal Cancer

Recruiting1 awardPhase 1 & 2

Coral Gables, Florida

This trial is testing a new treatment called ELI-002 7P for patients with specific types of cancer. The treatment helps the immune system recognize and attack these cancer cells. ELI-002 7P targets mutations that are common in various cancers and have been studied for their role in tumor growth and resistance to treatments.

Anti-tumor antibiotic

DZD9008 vs Chemotherapy for Lung Cancer

Recruiting2 awardsPhase 3

Plantation, Florida

"This trial is comparing a new drug called DZD9008 to standard chemotherapy in patients with a type of lung cancer called NSCLC that has a specific genetic mutation. The study aims to see

Radioisotope Therapy

Targeted Alpha-Particle Therapy for Neuroendocrine Tumors

Recruiting1 awardPhase 1 & 2

Miami, Florida

This trial is testing a new therapy to treat advanced neuroendocrine tumors using targeted alpha-particles.

Topoisomerase I inhibitors

Lurbinectedin +/- Irinotecan for Small Cell Lung Cancer

Recruiting2 awardsPhase 3

West Palm Beach, Florida

This trial is testing two different experimental treatments for small cell lung cancer that has returned after one other treatment. One experimental treatment is a single drug, and the other experimental treatment is a combination of two drugs. The trial will compare how well the experimental treatments work to a standard treatment.

Alkylating agents

Pembrolizumab SC vs IV for Lung Cancer

Recruiting2 awardsPhase 3

Hollywood, Florida

This trial is testing a new way to give the cancer drug pembrolizumab as an injection under the skin for people with advanced lung cancer. The goal is to see if this method works as well as the traditional IV method. The study will also check if it is safe and effective when used with standard chemotherapy.

Chemotherapy

Adagrasib + Pembrolizumab for Lung Cancer

Recruiting1 awardPhase 2 & 3

Miami, Florida

This trial tests two drugs, MRTX849 and pembrolizumab, in patients with advanced lung cancer who have a specific genetic mutation. MRTX849 targets the mutation to stop cancer growth, while pembrolizumab boosts the immune system to fight the cancer. The study aims to see how well these treatments work alone and together.

View More Related Trials

Frequently Asked Questions

Do I need insurance to participate in a trial?

Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).

Is there any support for travel costs?

Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.

Will I know what medication I am taking?

This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.

How long do clinical trials last?

Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.

Do you verify all the trials on your website?

All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.

How quickly will I hear back from a clinical trial?

Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.